Contact
searchSearch
HMP Global

Major Depressive Disorder Learning Library

Featured

Brittany Albright and Kristian Dambrino
Clinical Pearls
Avoiding Misdiagnosis in Major Depressive Disorder
09/30/2025
Kristian Dambrino, MSN, APRN, PMHNP; Brittany B. Albright, MD, MPH
Brittany Albright, MD, MPH, consultant, Psych Congress, and Kristian Dambrino, DNP, PMHNP-BC, consultant, Psych Congress, discuss common pitfalls when it comes to diagnosing MDD and TRD, as well as tools that clinicians have at their disposal...
Brittany Albright, MD, MPH, consultant, Psych Congress, and Kristian Dambrino, DNP, PMHNP-BC, consultant, Psych Congress, discuss common pitfalls when it comes to diagnosing MDD and TRD, as well as tools that clinicians have at their disposal...
Brittany Albright, MD, MPH,...
09/30/2025
Psych Congress NP Institute
Brittany Albright and Kristian Dambrino
Clinical Pearls
Knowing When to Refer a Patient for Esketamine
09/16/2025
Brittany B. Albright, MD, MPH; Kristian Dambrino, MSN, APRN, PMHNP
Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC,, discuss referral practices for esketamine and transcranial magnetic stimulation for patients with depression.
Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC,, discuss referral practices for esketamine and transcranial magnetic stimulation for patients with depression.
Brittany Albright, MD, MPH, and...
09/16/2025
Psych Congress NP Institute
Brittany Albright and Kristian Dambrino
Clinical Pearls
Reconceptualizing Treatment-Resistant Depression as Monoamine Treatment-Resistant Depression
09/08/2025
Brittany Albright, MD, MPH; Kristian Dambrino, MSN, APRN, PMHNP
Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC, discuss the difference between major depressive disorder and treatment-resistant depression, plus monoaminergic versus glutamatergic treatments.
Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC, discuss the difference between major depressive disorder and treatment-resistant depression, plus monoaminergic versus glutamatergic treatments.
Brittany Albright, MD, MPH, and...
09/08/2025
Psych Congress NP Institute
Andrew Penn and Saundra Jain
APP Perspectives
Integrating Psychotherapy Alongside Psychopharmacology
07/10/2025
Andrew Penn, RN, MS, NP, CNS, APRN-BC; Saundra Jain, MA, PsyD, LPC
Saundra Jain, MA, PsyD, LPC, and Andrew Penn, MS, PMHNP-BC, discuss the importance and utility of integrating psychotherapy into their everyday clinical practice.
Saundra Jain, MA, PsyD, LPC, and Andrew Penn, MS, PMHNP-BC, discuss the importance and utility of integrating psychotherapy into their everyday clinical practice.
Saundra Jain, MA, PsyD, LPC, and...
07/10/2025
Psych Congress NP Institute
Julie Carbray and Kristian Dambrino
Clinical Pearls
The Role of NMDA and AMPA Receptors in Rapid-Acting Antidepressant Treatments
05/07/2025
Julie A. Carbray, PhD, APRN; Kristian Dambrino, MSN, APRN, PMHNP
In part 1 of this series, Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, and Kristian Dambrino, DNP, PMHNP-BC, discuss the role NMDA and AMPA receptors play in rapid-acting depression treatment.
In part 1 of this series, Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, and Kristian Dambrino, DNP, PMHNP-BC, discuss the role NMDA and AMPA receptors play in rapid-acting depression treatment.
In part 1 of this series, Julie...
05/07/2025
Psych Congress NP Institute
What should be monitored when tapering a patient off an antidepressant?
Expert Insights Quiz
What should be monitored when tapering a patient off an antidepressant?
12/18/2024
Saundra Jain, MA, PsyD, LPC; Andrew Penn, RN, MS, NP, CNS, APRN-BC
Do you remember this pearl from a recent Q&A?
Do you remember this pearl from a recent Q&A?
Do you remember this pearl from...
12/18/2024
Psych Congress NP Institute
Penn and Jain
Clinical Pearls
Top Strategies for Deprescribing in MDD Care
12/16/2024
Andrew Penn, RN, MS, NP, CNS, APRN-BC; Saundra Jain, MA, PsyD, LPC
Experts discuss the importance of deprescribing in various disease states, shedding light on the nuances of managing medications for conditions like depression and schizophrenia.
Experts discuss the importance of deprescribing in various disease states, shedding light on the nuances of managing medications for conditions like depression and schizophrenia.
Experts discuss the importance...
12/16/2024
Psych Congress NP Institute
What is the first step when a patient's antidepressant stops working?
Expert Insights Quiz
What is the first step when a patient's antidepressant stops working?
12/13/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Test your knowledge with a quick quiz!
Test your knowledge with a quick quiz!
Test your knowledge with a quick...
12/13/2024
Psych Congress NP Institute
Kempf and Jain
Clinical Pearls
How can APPs best work with supervising doctors in TRD and MDD treatment?
12/05/2024
Rakesh Jain, MD, MPH, RD; Brooke Kempf, MSN, PMHNP-BC
Brooke Kempf and Rakesh Jain continue their discussion on depression treatment to discuss how APPs and MDs can collaborate to treat patients together.
Brooke Kempf and Rakesh Jain continue their discussion on depression treatment to discuss how APPs and MDs can collaborate to treat patients together.
Brooke Kempf and Rakesh Jain...
12/05/2024
Psych Congress NP Institute
pop quiz!
Quiz
What percentage of patients with TRD may have bipolar depression?
11/13/2024
Rakesh Jain, MD, MPH, RD; Brooke Kempf, MSN, PMHNP-BC
Time to test your knowledge with a pop quiz!
Time to test your knowledge with a pop quiz!
Time to test your knowledge with...
11/13/2024
Psych Congress NP Institute
Rakesh Jain and Brooke Kempf
Clinical Pearls
Using Comprehensive Management of TRD to Improve Patient Outcomes
11/05/2024
Brooke Kempf, MSN, PMHNP-BC; Rakesh Jain, MD, MPH, RD
Discover why careful diagnosis is crucial, how to leverage glutamatergic therapies, and the role of holistic methods like exercise and psychotherapy in improving patient outcomes. 
Discover why careful diagnosis is crucial, how to leverage glutamatergic therapies, and the role of holistic methods like exercise and psychotherapy in improving patient outcomes. 
Discover why careful diagnosis...
11/05/2024
Psych Congress NP Institute

Rapid Refreshers

Brooke and Amber
Rapid Refresh
Comparing MDD With Mixed Features and Bipolar I Disorder
04/10/2024
Amber Hoberg, NP, and Brooke Kemf answer the audience-posed question, "What are the differences between major depressive disorder (MDD) with mixed features and bipolar I disorder?"
Amber Hoberg, NP, and Brooke Kemf answer the audience-posed question, "What are the differences between major depressive disorder (MDD) with mixed features and bipolar I disorder?"
Amber Hoberg, NP, and Brooke...
04/10/2024
Psych Congress NP Institute
Amber and Desiree
Rapid Refresh
How to Properly Manage Missed Doses of Long-Acting Injectable Medications
08/12/2024
Amber Hoberg, MSN, APRN, PMHNP-BC; Desiree Matthews, PHMNP-BC
Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, explore how to tackle missed doses and follow prescribing instructions for different LAIs to ensure you are providing the best care possible for your patient with...
Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, explore how to tackle missed doses and follow prescribing instructions for different LAIs to ensure you are providing the best care possible for your patient with...
Desiree Matthews, PMHNP-BC, and...
08/12/2024
Psych Congress NP Institute
Julie Carbray
Rapid Refresh
Screening Tools for Adult and Pediatric ADHD
07/26/2024
Julie A. Carbray, PhD, APRN
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder.  
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder.  
Julie Carbray, PhD, FPMHNP-BC,...
07/26/2024
Psych Congress NP Institute
andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Brooke and Amber
Rapid Refresh
Comparing MDD With Mixed Features and Bipolar I Disorder
04/10/2024
Amber Hoberg, NP, and Brooke Kemf answer the audience-posed question, "What are the differences between major depressive disorder (MDD) with mixed features and bipolar I disorder?"
Amber Hoberg, NP, and Brooke Kemf answer the audience-posed question, "What are the differences between major depressive disorder (MDD) with mixed features and bipolar I disorder?"
Amber Hoberg, NP, and Brooke...
04/10/2024
Psych Congress NP Institute

Clinical Pearls

Brittany Albright and Kristian Dambrino
Clinical Pearls
Avoiding Misdiagnosis in Major Depressive Disorder
09/30/2025
Kristian Dambrino, MSN, APRN, PMHNP; Brittany B. Albright, MD, MPH
Brittany Albright, MD, MPH, consultant, Psych Congress, and Kristian Dambrino, DNP, PMHNP-BC, consultant, Psych Congress, discuss common pitfalls when it comes to diagnosing MDD and TRD, as well as tools that clinicians have at their disposal...
Brittany Albright, MD, MPH, consultant, Psych Congress, and Kristian Dambrino, DNP, PMHNP-BC, consultant, Psych Congress, discuss common pitfalls when it comes to diagnosing MDD and TRD, as well as tools that clinicians have at their disposal...
Brittany Albright, MD, MPH,...
09/30/2025
Psych Congress NP Institute
Brittany Albright and Kristian Dambrino
Clinical Pearls
Knowing When to Refer a Patient for Esketamine
09/16/2025
Brittany B. Albright, MD, MPH; Kristian Dambrino, MSN, APRN, PMHNP
Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC,, discuss referral practices for esketamine and transcranial magnetic stimulation for patients with depression.
Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC,, discuss referral practices for esketamine and transcranial magnetic stimulation for patients with depression.
Brittany Albright, MD, MPH, and...
09/16/2025
Psych Congress NP Institute
Brittany Albright and Kristian Dambrino
Clinical Pearls
Reconceptualizing Treatment-Resistant Depression as Monoamine Treatment-Resistant Depression
09/08/2025
Brittany Albright, MD, MPH; Kristian Dambrino, MSN, APRN, PMHNP
Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC, discuss the difference between major depressive disorder and treatment-resistant depression, plus monoaminergic versus glutamatergic treatments.
Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC, discuss the difference between major depressive disorder and treatment-resistant depression, plus monoaminergic versus glutamatergic treatments.
Brittany Albright, MD, MPH, and...
09/08/2025
Psych Congress NP Institute
Julie Carbray and Kristian Dambrino
Clinical Pearls
The Role of NMDA and AMPA Receptors in Rapid-Acting Antidepressant Treatments
05/07/2025
Julie A. Carbray, PhD, APRN; Kristian Dambrino, MSN, APRN, PMHNP
In part 1 of this series, Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, and Kristian Dambrino, DNP, PMHNP-BC, discuss the role NMDA and AMPA receptors play in rapid-acting depression treatment.
In part 1 of this series, Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, and Kristian Dambrino, DNP, PMHNP-BC, discuss the role NMDA and AMPA receptors play in rapid-acting depression treatment.
In part 1 of this series, Julie...
05/07/2025
Psych Congress NP Institute
Penn and Jain
Clinical Pearls
Top Strategies for Deprescribing in MDD Care
12/16/2024
Andrew Penn, RN, MS, NP, CNS, APRN-BC; Saundra Jain, MA, PsyD, LPC
Experts discuss the importance of deprescribing in various disease states, shedding light on the nuances of managing medications for conditions like depression and schizophrenia.
Experts discuss the importance of deprescribing in various disease states, shedding light on the nuances of managing medications for conditions like depression and schizophrenia.
Experts discuss the importance...
12/16/2024
Psych Congress NP Institute
Kempf and Jain
Clinical Pearls
How can APPs best work with supervising doctors in TRD and MDD treatment?
12/05/2024
Rakesh Jain, MD, MPH, RD; Brooke Kempf, MSN, PMHNP-BC
Brooke Kempf and Rakesh Jain continue their discussion on depression treatment to discuss how APPs and MDs can collaborate to treat patients together.
Brooke Kempf and Rakesh Jain continue their discussion on depression treatment to discuss how APPs and MDs can collaborate to treat patients together.
Brooke Kempf and Rakesh Jain...
12/05/2024
Psych Congress NP Institute
Rakesh Jain and Brooke Kempf
Clinical Pearls
Using Comprehensive Management of TRD to Improve Patient Outcomes
11/05/2024
Brooke Kempf, MSN, PMHNP-BC; Rakesh Jain, MD, MPH, RD
Discover why careful diagnosis is crucial, how to leverage glutamatergic therapies, and the role of holistic methods like exercise and psychotherapy in improving patient outcomes. 
Discover why careful diagnosis is crucial, how to leverage glutamatergic therapies, and the role of holistic methods like exercise and psychotherapy in improving patient outcomes. 
Discover why careful diagnosis...
11/05/2024
Psych Congress NP Institute
Jain and Kempf
Clinical Pearls
Targeting Non-Monoaminergic Pathways in MDD and TRD Treatment
09/30/2024
Rakesh Jain, MD, MPH, RD; Brooke Kempf, MSN, PMHNP-BC
Learn how this critical neurotransmitter is reshaping our understanding of depression, cognition, and mood disorders.
Learn how this critical neurotransmitter is reshaping our understanding of depression, cognition, and mood disorders.
Learn how this critical...
09/30/2024
Psych Congress NP Institute
Jain and Kempf
Clinical Pearls
Unmet Needs and Limitations in TRD and MDD Treatment
09/26/2024
Rakesh Jain, MD, MPH, RD; Brooke Kempf, MSN, PMHNP-BC
Explore the current challenges in treating MDD in a discussion with Brooke Kempf, MSN, PMHNP-BC, and Rakesh Jain, MD, MPH.
Explore the current challenges in treating MDD in a discussion with Brooke Kempf, MSN, PMHNP-BC, and Rakesh Jain, MD, MPH.
Explore the current challenges...
09/26/2024
Psych Congress NP Institute
amber hoberg, np
Clinical Pearls
What to Do When an Antidepressant Stops Working Effectively
08/30/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Nurse Practitioner Amber Hoberg, MSN, APRN, PMHNP-BC, provides insights on identifying when antidepressants may cease to be effective and offers practical strategies for adjusting treatment.
Nurse Practitioner Amber Hoberg, MSN, APRN, PMHNP-BC, provides insights on identifying when antidepressants may cease to be effective and offers practical strategies for adjusting treatment.
Nurse Practitioner Amber Hoberg,...
08/30/2024
Psych Congress NP Institute
Julie Carbray, PhD, APRN, PMHNP-BC
Clinical Pearls
Addressing Side Effects: Advances in Bipolar Disorder Treatment
10/28/2025
Julie A. Carbray, PhD, APRN
Julie Carbray, PhD, PMHNP-BC, APRN, discusses how emerging therapies for bipolar disorder differ from traditional mood stabilizers, including improved tolerability and reduced side effects.
Julie Carbray, PhD, PMHNP-BC, APRN, discusses how emerging therapies for bipolar disorder differ from traditional mood stabilizers, including improved tolerability and reduced side effects.
Julie Carbray, PhD, PMHNP-BC,...
10/28/2025
Psych Congress NP Institute
Julie Carbray, PhD, APRN, PMHNP-BC
Clinical Pearls
Managing Cardiometabolic Adverse Effects in Bipolar Disorder
10/15/2025
Julie A. Carbray, PhD, APRN
Julie Carbray, PhD, PMHNP-BC, APRN, provides an overview of some of the key cardiometabolic symptoms and adverse effects that clinicians should be on the lookout for in their patients with bipolar disorder.
Julie Carbray, PhD, PMHNP-BC, APRN, provides an overview of some of the key cardiometabolic symptoms and adverse effects that clinicians should be on the lookout for in their patients with bipolar disorder.
Julie Carbray, PhD, PMHNP-BC,...
10/15/2025
Psych Congress NP Institute
Brittany Albright and Kristian Dambrino
Clinical Pearls
Avoiding Misdiagnosis in Major Depressive Disorder
09/30/2025
Kristian Dambrino, MSN, APRN, PMHNP; Brittany B. Albright, MD, MPH
Brittany Albright, MD, MPH, consultant, Psych Congress, and Kristian Dambrino, DNP, PMHNP-BC, consultant, Psych Congress, discuss common pitfalls when it comes to diagnosing MDD and TRD, as well as tools that clinicians have at their disposal...
Brittany Albright, MD, MPH, consultant, Psych Congress, and Kristian Dambrino, DNP, PMHNP-BC, consultant, Psych Congress, discuss common pitfalls when it comes to diagnosing MDD and TRD, as well as tools that clinicians have at their disposal...
Brittany Albright, MD, MPH,...
09/30/2025
Psych Congress NP Institute
Brittany Albright and Kristian Dambrino
Clinical Pearls
Knowing When to Refer a Patient for Esketamine
09/16/2025
Brittany B. Albright, MD, MPH; Kristian Dambrino, MSN, APRN, PMHNP
Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC,, discuss referral practices for esketamine and transcranial magnetic stimulation for patients with depression.
Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC,, discuss referral practices for esketamine and transcranial magnetic stimulation for patients with depression.
Brittany Albright, MD, MPH, and...
09/16/2025
Psych Congress NP Institute
Brittany Albright and Kristian Dambrino
Clinical Pearls
Reconceptualizing Treatment-Resistant Depression as Monoamine Treatment-Resistant Depression
09/08/2025
Brittany Albright, MD, MPH; Kristian Dambrino, MSN, APRN, PMHNP
Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC, discuss the difference between major depressive disorder and treatment-resistant depression, plus monoaminergic versus glutamatergic treatments.
Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC, discuss the difference between major depressive disorder and treatment-resistant depression, plus monoaminergic versus glutamatergic treatments.
Brittany Albright, MD, MPH, and...
09/08/2025
Psych Congress NP Institute
Hara Oyedeji
Clinical Pearls
Considering Oral Overlap Requirements When Initiating LAIs
06/18/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, offers guidance to APPs navigating LAI initiation while considering oral overlap requirements in the treatment of schizophrenia.
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, offers guidance to APPs navigating LAI initiation while considering oral overlap requirements in the treatment of schizophrenia.
In this video, Hara Oyedeji,...
06/18/2025
Psych Congress NP Institute
Hara Oyedeji
Videos
Expanding Your Schizophrenia Toolkit With Xanomeline-Trospium
06/10/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In part 2 of this series, Hara Oyedeji, APRN, PMHNP-BC, MSEd, unpacks the use and benefits of xanomeline-trospium as a treatment option for schizophrenia.
In part 2 of this series, Hara Oyedeji, APRN, PMHNP-BC, MSEd, unpacks the use and benefits of xanomeline-trospium as a treatment option for schizophrenia.
In part 2 of this series, Hara...
06/10/2025
Psych Congress NP Institute
Hara Oyedeji
Videos
Effectively Managing Clozapine for Treatment-Resistant Schizophrenia
05/22/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, explores how APPs can most effectively prescribe and monitor patient progress on clozapine, the only FDA-approved treatment for treatment-resistant schizophrenia.
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, explores how APPs can most effectively prescribe and monitor patient progress on clozapine, the only FDA-approved treatment for treatment-resistant schizophrenia.
In this video, Hara Oyedeji,...
05/22/2025
Psych Congress NP Institute
Julie Carbray and Kristian Dambrino
Clinical Pearls
The Role of NMDA and AMPA Receptors in Rapid-Acting Antidepressant Treatments
05/07/2025
Julie A. Carbray, PhD, APRN; Kristian Dambrino, MSN, APRN, PMHNP
In part 1 of this series, Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, and Kristian Dambrino, DNP, PMHNP-BC, discuss the role NMDA and AMPA receptors play in rapid-acting depression treatment.
In part 1 of this series, Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, and Kristian Dambrino, DNP, PMHNP-BC, discuss the role NMDA and AMPA receptors play in rapid-acting depression treatment.
In part 1 of this series, Julie...
05/07/2025
Psych Congress NP Institute
headshot of Dr Craig Chepke
Videos
Effective Communication Strategies for Introducing LAIs in Telemedicine Settings
04/16/2025
Craig Chepke, MD, DFAPA
In this video, Craig Chepke, MD, DFAPA, discusses effective communication strategies clinicians can use when introducing long-acting injectable (LAI) antipsychotics to patients for the treatment of schizophrenia.
In this video, Craig Chepke, MD, DFAPA, discusses effective communication strategies clinicians can use when introducing long-acting injectable (LAI) antipsychotics to patients for the treatment of schizophrenia.
In this video, Craig Chepke, MD,...
04/16/2025
Psych Congress Network

Expert Insights Quizzes

What should be monitored when tapering a patient off an antidepressant?
Expert Insights Quiz
What should be monitored when tapering a patient off an antidepressant?
12/18/2024
Saundra Jain, MA, PsyD, LPC; Andrew Penn, RN, MS, NP, CNS, APRN-BC
Do you remember this pearl from a recent Q&A?
Do you remember this pearl from a recent Q&A?
Do you remember this pearl from...
12/18/2024
Psych Congress NP Institute
What is the first step when a patient's antidepressant stops working?
Expert Insights Quiz
What is the first step when a patient's antidepressant stops working?
12/13/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Test your knowledge with a quick quiz!
Test your knowledge with a quick quiz!
Test your knowledge with a quick...
12/13/2024
Psych Congress NP Institute
pop quiz!
Quiz
What percentage of patients with TRD may have bipolar depression?
11/13/2024
Rakesh Jain, MD, MPH, RD; Brooke Kempf, MSN, PMHNP-BC
Time to test your knowledge with a pop quiz!
Time to test your knowledge with a pop quiz!
Time to test your knowledge with...
11/13/2024
Psych Congress NP Institute
What is the most exciting neurotransmitter in depression treatment?
Quiz
What is the most exciting neurotransmitter in depression treatment?
10/07/2024
Rakesh Jain, MD, MPH, RD; Brooke Kempf, MSN, PMHNP-BC
Test your knowledge with a quick quiz!
Test your knowledge with a quick quiz!
Test your knowledge with a quick...
10/07/2024
Psych Congress NP Institute
Which traits should clinicians look for when diagnosing MDD and bipolar disorder?
Quiz
Which traits should clinicians look for when diagnosing MDD and bipolar disorder?
09/25/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Do you remember this interview?
Do you remember this interview?
Do you remember this interview?
09/25/2024
Psych Congress NP Institute
Pop quiz written on a blackboard with white chalk
Guidelines Quiz
Side Effect Monitoring on Clozapine
07/22/2025
Test your guideline knowledge with this quiz!
Test your guideline knowledge with this quiz!
Test your guideline knowledge...
07/22/2025
Psych Congress NP Institute
What should be monitored when tapering a patient off an antidepressant?
Expert Insights Quiz
What should be monitored when tapering a patient off an antidepressant?
12/18/2024
Saundra Jain, MA, PsyD, LPC; Andrew Penn, RN, MS, NP, CNS, APRN-BC
Do you remember this pearl from a recent Q&A?
Do you remember this pearl from a recent Q&A?
Do you remember this pearl from...
12/18/2024
Psych Congress NP Institute
What is the first step when a patient's antidepressant stops working?
Expert Insights Quiz
What is the first step when a patient's antidepressant stops working?
12/13/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Test your knowledge with a quick quiz!
Test your knowledge with a quick quiz!
Test your knowledge with a quick...
12/13/2024
Psych Congress NP Institute
pop quiz!
Quiz
What percentage of patients with TRD may have bipolar depression?
11/13/2024
Rakesh Jain, MD, MPH, RD; Brooke Kempf, MSN, PMHNP-BC
Time to test your knowledge with a pop quiz!
Time to test your knowledge with a pop quiz!
Time to test your knowledge with...
11/13/2024
Psych Congress NP Institute
Jonathan Meyer
Quiz
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments?
10/23/2024
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments? Take the quiz to find out!
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments? Take the quiz to find out!
How do muscarinic acetylcholine...
10/23/2024
Psych Congress NP Institute
What is the most exciting neurotransmitter in depression treatment?
Quiz
What is the most exciting neurotransmitter in depression treatment?
10/07/2024
Rakesh Jain, MD, MPH, RD; Brooke Kempf, MSN, PMHNP-BC
Test your knowledge with a quick quiz!
Test your knowledge with a quick quiz!
Test your knowledge with a quick...
10/07/2024
Psych Congress NP Institute
Which traits should clinicians look for when diagnosing MDD and bipolar disorder?
Quiz
Which traits should clinicians look for when diagnosing MDD and bipolar disorder?
09/25/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Do you remember this interview?
Do you remember this interview?
Do you remember this interview?
09/25/2024
Psych Congress NP Institute
LAI representation
Quiz
What is the next step if a patient misses a dose of an LAI medication?
08/15/2024
Meagan Thistle
When managing a patient who has missed a dose of a long-acting injectable (LAI), what is the recommended first step according to a recent expert interview?
When managing a patient who has missed a dose of a long-acting injectable (LAI), what is the recommended first step according to a recent expert interview?
When managing a patient who has...
08/15/2024
Psych Congress NP Institute
quiz
Expert Insights Quiz
What is most important when matching antipsychotic interventions to clinical factors for a patient?
08/08/2024
According to Amber Hoberg, MSN, APRN, PMHNP-BC, when matching antipsychotic interventions to clinical factors for a patient, what is the most important consideration?
According to Amber Hoberg, MSN, APRN, PMHNP-BC, when matching antipsychotic interventions to clinical factors for a patient, what is the most important consideration?
According to Amber Hoberg, MSN,...
08/08/2024
Psych Congress NP Institute
An illustration of a pencil marking answers on a quiz sheet.
Quiz
Which ADHD screening tools can be found online?
07/30/2024
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
07/30/2024
Psych Congress NP Institute
Psych NP Institute

 

Advance Your Expertise & Gain Confidence in Your Approach at NP Institute!

Nurse Practitioners play a vital role in mental healthcare, and specialized education is key to creating the best patient outcomes. Join us at NP Institute for an in-depth, practical learning experience designed to cover everything you’ve wanted to know but have been afraid to ask.

Why Attend?

  • Expert-Led Education – Learn from world-class leaders in psychiatry
  • Deep Dive into Psychopharmacology – Master essential principles, treatments, and medications
  • Practical & Actionable – Gain confidence in your approach to manage complex cases
  • Tailored for NPs – Networking opportunities with like-minded professionals and education designed to fit your unique role in mental healthcare

Join us to expand your knowledge and enhance patient care! 

REGISTER NOW

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use